Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayChange DetectedRHYNS syndrome was added as a related term in the study record. This improves indexing and discoverability without changing the study procedures.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter now shows Revision: v3.4.2, and older notices about government funding and operating status have been removed.SummaryDifference0.5%

- Check58 days agoChange DetectedA new site-wide notice warns that information may not be up to date due to a lapse in government funding, with guidance to check cc.nih.gov and opm.gov for updates. The page revision also updates to Revision: v3.4.1.SummaryDifference0.5%

- Check65 days agoChange DetectedMinor UI/text updates include a new 'Show glossary' option, capitalization/phrase tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the site revision 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.